Funding for this research was provided by:
Intellectual and Developmental Disabilities Research Center (HD103526)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD036071)
Article History
Received: 13 April 2022
Revised: 26 May 2022
Accepted: 27 May 2022
First Online: 20 June 2022
Change Date: 20 October 2022
Change Type: Update
Change Details: Typographical error in Figure 1. The word ‘increased’ in the box in the right hand side of the figure 1 is spelt wrongly and it has been updated.
Declarations
:
: RA and DP have no competing interests pertinent to this publication. RH has received funding from Azrieli Foundation for treatment studies in fragile X syndrome and she has consulted with Zynerba about treatment in fragile X syndrome.
: Not Applicable.
: Not Applicable.